Sareum Holdings PLC

Sareum Holdings PLC

Health CarePharmaceuticals & Biotechnology
  • Price (GBX)6.30
  • Today's Change-0.35 / -5.26%
  • Shares traded6.09m
  • 1 Year change+707.69%
  • Beta-0.2514
Data delayed at least 20 minutes, as of Sep 21 2021 17:08 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Key statistics

On Tuesday, Sareum Holdings PLC (SAR:LSE) closed at 6.30, -37.00% below its 52-week high of 10.00, set on Aug 06, 2021.
52-week range
0.703Sep 25 202010.00Aug 06 2021
Markit short selling activity
Previous close6.65
Average volume6.70m
Shares outstanding3.37bn
Free float3.22bn
P/E (TTM)--
Market cap223.82m GBP
EPS (TTM)-0.0003
Data delayed at least 20 minutes, as of Sep 21 2021 17:08 BST.
More ▼

Board of Directors


Stephen Parker, Non-Executive Chairman


Tim Mitchell, Founder and CEO


John Reader, Founder and CSO


Michael Owen, Non-Executive Director


Clive Birch, Non-Executive Director


Head Office:
Sareum Limited
Unit 2A, Langford Arch
London Road, Pampisford
CB22 3FX
United Kingdom

T: +44 (0) 1223 497700
F: +44 (0) 1223 497701
E: info@sareum.co.uk
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.